Bacillus Calmette Guerin (BCG) immunotherapy for bladder cancer: a control and mathematical analysis
From MaRDI portal
Publication:2114503
Recommendations
- Mathematical model of BCG immunotherapy in superficial bladder cancer
- Treatment of bladder cancer using BCG immunotherapy: PDE modeling
- PDE modeling of bladder cancer treatment using BCG immunotherapy
- Mathematical model of pulsed immunotherapy for superficial bladder cancer
- A mathematical model of combined \textit{bacillus Calmette-Guerin} (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancer
Cites work
- A nonstandard finite difference scheme for the modeling and nonidentical synchronization of a novel fractional chaotic system
- Analysis and dynamical behavior of fractional-order cancer model with vaccine strategy
- Cancer immunotherapy, mathematical modeling and optimal control
- Continuous and discrete mathematical models of tumor-induced angiogenesis
- Control and nonlinearity.
- Control of an artificial Human pancreas
- Hyperchaotic behaviors, optimal control, and synchronization of a nonautonomous cardiac conduction system
- MATHEMATICAL MODELING OF IN-VIVO TUMOR-IMMUNE INTERACTIONS FOR THE CANCER IMMUNOTHERAPY USING MATURED DENDRITIC CELLS
- Mathematical Models of Avascular Tumor Growth
- Mathematical analysis of a mathematical model of chemovirotherapy: effect of drug infusion method
- Mathematical model of BCG immunotherapy in superficial bladder cancer
- Mathematical modelling for the role of CD\(4^+\)T cells in tumor-immune interactions
- Modeling immunotherapy of the tumor -- immune interaction
- Modelling and mathematical problems related to tumor evolution and its interaction with the immune system
- On a nonlinear dynamical system with both chaotic and nonchaotic behaviors: a new fractional analysis and control
- Regular Synthesis and Sufficiency Conditions for Optimality
Cited in
(6)- Stability analysis of delayed immune response BCG infection in bladder cancer treatment model by stochastic perturbations
- Treatment of bladder cancer using BCG immunotherapy: PDE modeling
- Improving Bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer by adding interleukin 2 (IL-2): a mathematical model
- A fractional-order bladder cancer model with BCG treatment effect
- Mathematical model of BCG immunotherapy in superficial bladder cancer
- A stochastic optimal control model for BCG immunotherapy in superficial bladder cancer
This page was built for publication: Bacillus Calmette Guerin (BCG) immunotherapy for bladder cancer: a control and mathematical analysis
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2114503)
